FDA Approved: ZEMBRACE SYMTOUCH — Supplemental Application (Upsher-Smith laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Zembrace SymTouch (sumatriptan succinate) from Upsher-Smith Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• ZEMBRACE SYMTOUCH (Sumatriptan succinate)

Snippet

SUPPL AP for ZEMBRACE SYMTOUCH (SUMATRIPTAN SUCCINATE)